NCT05785871View on ClinicalTrials.gov

Hypertension, Brain Clearance, and Markers of Neurodegeneration

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

November 18, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Mild Cognitive ImpairmentHypertension
Trial Locations (1)

10065

Weill Cornell Medicine, New York

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Weill Medical College of Cornell University

OTHER

NCT05785871 - Hypertension, Brain Clearance, and Markers of Neurodegeneration | Biotech Hunter | Biotech Hunter